TY - JOUR T1 - Gaps in Sexually Transmitted Infection Screening among Men who Have Sex with Men in PrEP Care in the United States JF - medRxiv DO - 10.1101/2020.03.06.20032318 SP - 2020.03.06.20032318 AU - Christina Chandra AU - Kevin M. Weiss AU - Colleen F. Kelley AU - Julia L. Marcus AU - Samuel M. Jenness Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/18/2020.03.06.20032318.abstract N2 - Background The U.S. Centers for Disease Control and Prevention (CDC) recommends comprehensive sexually transmitted infection (STI) screening every 3–6 months for men who have sex with men (MSM) using HIV preexposure prophylaxis (PrEP). The gaps between these recommendations and clinical practice by region have not been quantified.Methods We used survey data collected from the internet-based ARTnet study between 2017 and 2019 on STI screening among MSM across the U.S., stratified by current, prior, and never PrEP use. Poisson regression models with robust error variance were used to model factors, including residence in the Southeast, associated with consistent (“always” or “sometimes”) exposure site-specific STI screening during PrEP care.Results Of 3259 HIV-negative MSM, 19% were currently using PrEP, 6% had used PrEP in the past, and 75% had never used PrEP. Among ever PrEP users, 87%, 78%, 57%, and 64% reported consistent screening for STIs by blood sample, urine sample or urethral swab, rectal swab, or pharyngeal swab, respectively, during PrEP care. Compared to PrEP users in all other regions, PrEP users in the Southeast were significantly less likely to be consistently screened for urogenital (adjusted prevalence ratio [aPR], 0.86; 95% confidence interval [CI], 0.76–0.98) and rectal STIs (aPR, 0.76; 95% CI, 0.62–0.93) during PrEP care.Conclusions Substantial gaps exist between CDC recommendations for STI screening during PrEP care and current clinical practice, particularly for rectal and pharyngeal exposure sites that can harbor asymptomatic infections and for MSM in Southeast states where the STI burden is substantial.SUMMARY Nearly half of U.S. men who have sex with men in PrEP care are not receiving consistent bacterial STI screening at sites of sexual exposure, and levels are worse in the Southeast region where the burden of STI is highest.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institutes of Health grant R21 MH112449.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnalysis scripts are provided in a Github repository are provided in a repository linked below. Primary data is available for analysis with a data use agreement available from the corresponding author. https://github.com/EpiModel/PrEP-STI-Test ER -